| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA615193 | F | Effective dose required for inhibitory activity against 1A9 human tumor cell line. | Homo sapiens | 26 | cell-based format | Scientific Literature | ||
| 2. | ALA619573 | F | Effective dose required for inhibitory activity against A549 human tumor cell line. | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
| 3. | ALA652538 | F | Effective dose required for inhibitory activity against CAK1 human tumor cell line; Not active | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
| 4. | ALA689359 | F | Effective dose required for inhibitory activity against HCT-8 human tumor cell line. | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
| 5. | ALA687208 | F | Compound at 1 uM was tested in vitro to inhibit proliferation of HL-60 leukemia cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 6. | ALA687209 | F | Compound at 10 uM was tested in vitro to inhibit proliferation of HL-60 leukemia cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 7. | ALA687210 | F | Compound at 100 uM was tested in vitro to inhibit proliferation of HL-60 leukemia cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 8. | ALA689326 | F | Effective dose required for inhibitory activity against HOS human tumor cell line. | Homo sapiens | 23 | cell-based format | Scientific Literature | ||
| 9. | ALA702350 | F | Effective dose required for inhibitory activity against KB human tumor cell line. | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
| 10. | ALA704645 | F | Effective dose required for inhibitory activity against KB-VIN human tumor cell line. | Homo sapiens | 28 | cell-based format | Scientific Literature | ||
| 11. | ALA700216 | F | Compound at 1 uM was tested in vitro to inhibit proliferation of K562 leukemia cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 12. | ALA700217 | F | Compound at 10 uM was tested in vitro to inhibit proliferation of K562 leukemia cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 13. | ALA700218 | F | Compound at 100 uM was tested in vitro to inhibit proliferation of K562 leukemia cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 14. | ALA712001 | F | Effective dose required for inhibitory activity against MCF-7 human tumor cell line. | Homo sapiens | 24 | cell-based format | Scientific Literature | ||
| 15. | ALA759712 | F | Effective dose required for inhibitory activity against PC-3 human tumor cell line; Not active | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA762583 | F | Percent inhibition against PTX10 human tumor cell line at >10 ug/mL | Homo sapiens | 18 | cell-based format | Scientific Literature | ||
| 17. | ALA808258 | F | Effective dose required for inhibitory activity against SK-MEL-2 human tumor cell line; Not active | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 18. | ALA928337 | F | Antiproliferative activity against human HBC4 cells by sulforhodamine B assay relative to control | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 19. | ALA928338 | F | Antiproliferative activity against human BSY1 cells by sulforhodamine B assay relative to control | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 20. | ALA928339 | F | Antiproliferative activity against human HBC5 cells by sulforhodamine B assay relative to control | Homo sapiens | 6 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!